OcuTerra Therapeutics
PrivateCompany Overview
OcuTerra Therapeutics is a biotechnology company that developed non-invasive eye drop treatments for diabetic eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
diabetic retinopathyophthalmologybiotechnologyeye drop treatmentclinical trialintegrin inhibitordrug developmentnon-proliferative diabetic retinopathyNPDRproliferative diabetic retinopathyPDRsmall-molecule drugeye carebiotech startup
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OcuTerra Therapeutics Comparables
Compare OcuTerra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exonate | 85% | |
| Panoptica | 84% | |
| Retinset, S.L. | 82% | |
OcuTerra Therapeutics Funding Rounds
Historical fundraising activity
OcuTerra Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OcuTerra Therapeutics's valuation, stock price, and market status.